Early BCG vaccination and development of atopy

Lancet

Volumn 350, Issue 9075, 1997, Pages 400-403

  Alm, Johan S ^a   Lilja, Gunnar ^a   Pershagen, Göran ^a   Scheynius, Annika ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; IMMUNOGLOBULIN E ANTIBODY;

ARTICLE; ATOPY; BCG VACCINATION; CHILD; COHORT ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; PARENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEROLOGY; SKIN TEST; SWEDEN; TUBERCULOSIS;

EID: 0030758067     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)02207-1     Document Type: Article

References (28)

1. Taylor B, Wadsworth J, Wadsworth M, Peckham C. Changes in the reported prevalence of childhood eczema since the 1939-45 war. Lancet 1984; ii: 1255-57.
2. Burney PGJ, Chinn S, Rona RJ. Has the prevalence of asthma increased in children? Evidence from the national study of health and growth 1973-86. BMJ 1990; 300: 1306-10.
3. Bråbäck L, Breborowicz A, Dreborg S, Knutsson A, Pieklik H, Björkstén B. Atopic sensitization and respiratory symptoms among Polish and Swedish school children. Clin Exp Allergy 1994; 24: 826-35.
4. Wichmann HE. Possible explanation for the different trends of asthma and allergy in east and west Germany. Clin Exp Allergy 1996; 26: 621-23.
5. Romagani S. Induction of Th1 and Th2 responses: a key role for the "natural" immune response? Immunol Today 1992; 13: 379-81.
6. Del Prete G. Human Th1 and Th2 lymphocytes: their role in the pathophysiology of atopy. Allergy 1992; 47: 450-55.
7. Mehra VL, Salgame P, Snapper SB, Lugosi L, Jacobs W, Bloom BR. Vaccines against leprosy. In: Woodrow CG, Levine MM, eds. New generation vaccines. New York: Marcel Dekker, 1990: 611-17.
8. Sander B, Skansén-Saphir U, Damm O, Håkansson L, Andersson U. Sequential production of Th1 and Th2 cytokines in response to live bacillus Calmette-Guérin. Immunology 1995; 86: 512-18.
9. Harada M, Kishimoto Y, Makino S. Prevention of overt diabetes and insulitis in NOD mice by single BCG vaccination. Diabetes Res Clin Pract 1990; 8: 85-89.
10. Shehadeh N, Calcinaro F, Bradley BJ, Bruchlim I, Vardi P, Laffert KJ. Effect of adjuvant therapy on development of diabetes in mouse and man. Lancet 1994; 343: 706-07.
11. Romanus V, Svensson Å, Hallander HO. The impact of changing BCG coverage on tuberculosis incidence in Swedish-born children between 1969 and 1989. Tuber Lung Dis 1992; 73: 150-61.
12. Aurelius G. The Child Health Care in Stockholm County Council: annual report 1995. Serafen, Stockholm: The Child Health Care in Stockholm County Council, 1995: 20.
13. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Dermatol Venereol 1980; 92 (suppl): 44-47.
14. Larsson LO. Sensitivity to sensitins and tuberculin in Swedish children. Gothenburg, Sweden: Dissertation, Department of Pulmonary Medicine, University of Gothenburg, 1991: 6-13.
15. Pepys J. Clinical aspects of immunology, 3rd edn. Oxford: Blackwell Scientific Publications, 1975: 877-902.
16. Casagrande JT, Pike MC, Smith PG. An improved approximate formula for calculating sample size for comparing two binomial distributions. Biometrics 1978; 34: 483-86.
17. Sigurs N, Hattevig G, Kjellman B. Maternal avoidance of eggs, cow's milk and fish during lactation: effect on allergic manifestations, skin-prick tests, and specific IgE antibodies in children at age 4 years. Paediatrics 1992; 89: 735-39.
18. Lilja G, Öhman H, Johansson SGO. Development of atopic disease during childhood and its prediction by Phadiatop Paediatric. Clin Exp Allergy 1996: 26: 1073-79.
19. Kjellman N-IM. Atopic disease in seven-year-old children. Acta Paediatr Scand 1977; 66: 465-71.
20. Rylander E, Pershagen G, Eriksson M, Nordvall L. Parental smoking and other risk factors for wheezing bronchitis in children. Eur J Epidemiol 1993; 9: 517-26.
21. Kajosaari M. Atopy prevention in childhood: the role of diet. Pediatr Allergy Immunol 1994; 5 (suppl 1): 26-28.
22. Colditz GA, Berkey CS, Mosteller F, et al. The efficacy of bacillus Calmette-Guérin vaccination of new-borns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Paediatrics 1995; 96: 29-35.
23. Al-Kassmi FA, Al-Hajjaj MS, Al-Orainey IO, Bamgboye EA. Does the protective effect of neonatal BCG correlate with vaccine-induced tuberculin reaction? Am J Respir Crit Care Med 1995; 152: 1575-78.
24. Shirakawa T, Enomoto T, Shimazu S, Hopkin J. The inverse association between tuberlin responses and atopic disorder. Science 1997; 275: 77-79.
25. Romanus V. The Swedish tuberculosis index 1991-94. Stockholm: The Swedish Institute for Infectious Disease Control and the Swedish Heart-Lung Foundation, 1996.
26. Shaheen SO, Aaby P, Hall AJ, Barker DJP, Heyes CB, Shiell AW. Measles and atopy in Guinea-Bissau. Lancet 1996; 347: 1792-96.
27. Ward BJ, Johnson RT, Vaisberg A, Jauregui E, Griffin DE. Cytokine production in vitro and the lymphoproliferative defect of natural measles virus infection. Clin Immunol Immunopathol 1991; 61: 236-48.
28. Ward BJ, Griffin DE. Changes in cytokine production after measles virus vaccination: predominant production of IL-4 suggests induction of a Th2 response. Clin Immunol Immunopathol 1993; 67: 171-77.